Prospective randomized study comparing the efficacy of bioequivalent doses of glycosylated and nonglycosylated rG-CSF for mobilizing peripheral blood progenitor cells

British Journal of Haematology

Volumn 96, Issue 2, 1997, Pages 418-420

  De Arriba, F ^a   Lozano, M L ^a   Ortuno F ^a   Heras, I ^a   Moraleda, J M ^a   Vicente, V ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

Author keywords

CD34; filgrastim; granulocyte colony stimulating factor; lenograstim; mobilization

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LEUKAPHERESIS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031047031     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.d01-2029.x     Document Type: Article

References (12)

1. Höglund, M., Bengtsson, M., Cour-Chabernaud, V., Dabouz-Harrouche, F., Simonsson, B., Smedmyr, B. & Tötterman, T. (1995) Glycosylated rHuG-CSF is more potent than non-glycosylated rHuG-CSF in mobilisation of peripheral blood progenitor cells (PBPC) in healthy volunteers. Blood, 86, (Suppl. 1), 464a.
2. - hematopoietic stem cells. Blood, 83, 1515-1526.
3. ++/CD38 progenitor cells in long-term cultures and semisolid assays. Blood, 81, 2916-2924.
4. + peripheral blood progenitor cells. Annals of Hematology, 71, 105-110.
5. Mire-Sluis, R., Gaines Das, R. & Thorpe, R. (1995) The international standard for granulocyle colony stimulating factor (G-CSF): evaluation in an international collaborative study, Journal of Immunological Methods, 179, 117-126.
6. + human fetal liver progenitors with a high proliferative potential, Blood, 83, 3170-3181.
7. Nissen, C. (1994) Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency. European Journal of Cancer. 30A, (Suppl. 3), 12-14.
8. Nissen, C., Dalle Carbonare, V. & Moser, Y. (1944) In vitro comparison of the biological potency of glycosylated versus nonglycosylated rG-CSF. Drug Investigation, 7, 346-352.
9. Sutherland, H.J., Lansdorp, P.M., Henkelman, D.H., Eaves, A.C. & Eaves, C.J. (1990) Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stroma layers. Proceedings of the National Academy of Sciences of the United States of America, 87, 3584-3588.
10. Udomsakdi, C., Lansdorp, P.M., Hogge, D.E., Reid, D.S., Eaves, A.C. & Eaves, C.J. (1992) Characterization of primitive hematopoietic cells in normal human peripheral blood. Blood, 80, 2513-2521.
11. Verfaillie, C.M. (1992) Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vivo hematopoiesis, Blood, 79, 2821-2826.
12. World Health Organization (1994) Technical Report Series no. 840, p. 10.